Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,296,000 | 5,338,000 | 4,362,000 | 4,893,000 | 4,065,000 |
| Marketable Securities | 1,029,000 | 1,182,000 | 1,376,000 | 1,632,000 | 1,601,000 |
| Receivables | 3,787,000 | 4,493,000 | 4,566,000 | 4,149,000 | 3,925,000 |
| Inventories | 1,482,000 | 1,618,000 | 1,676,000 | 1,772,000 | 1,779,000 |
| TOTAL | $12,629,000 | $14,772,000 | $13,991,000 | $13,925,000 | $13,278,000 |
| Non-Current Assets | |||||
| PPE Net | 5,253,000 | 5,121,000 | 5,037,000 | 4,996,000 | 4,990,000 |
| Investments And Advances | 1,427,000 | 1,309,000 | 1,099,000 | 836,000 | 579,000 |
| Intangibles | 38,645,000 | 41,787,000 | 42,232,000 | 42,675,000 | 43,115,000 |
| Other Non-Current Assets | 5,126,000 | 4,963,000 | 4,739,000 | 5,552,000 | 5,530,000 |
| TOTAL | $50,451,000 | $53,180,000 | $53,107,000 | $54,059,000 | $54,214,000 |
| Total Assets | $63,080,000 | $67,952,000 | $67,098,000 | $67,984,000 | $67,492,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,025,000 | 1,516,000 | 2,511,000 | 2,261,000 | 2,259,000 |
| Accounts payable and accrued liabilities | 583,000 | 705,000 | 585,000 | 608,000 | 570,000 |
| Accrued Expenses | 3,450,000 | 3,244,000 | 3,368,000 | 3,290,000 | 3,369,000 |
| TOTAL | $8,558,000 | $11,610,000 | $10,245,000 | $10,214,000 | $9,705,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,127,000 | 26,155,000 | 26,137,000 | 27,914,000 | 29,337,000 |
| aiOther Non-Current Liabilities | 4,800,000 | 4,773,000 | 4,648,000 | 5,777,000 | 5,029,000 |
| TOTAL | $34,607,000 | $35,278,000 | $35,382,000 | $38,060,000 | $38,823,000 |
| Total Liabilities | $43,165,000 | $46,888,000 | $45,627,000 | $48,274,000 | $48,528,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,254,313 | 1,253,887 | 1,254,383 | 1,253,809 | 1,254,178 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 14,986,000 | 16,324,000 | 16,903,000 | 15,392,000 | 14,821,000 |
| Other shareholders' equity | 61,000 | 78,000 | 75,000 | 46,000 | 50,000 |
| TOTAL | $19,915,000 | $21,064,000 | $21,471,000 | $19,710,000 | $18,964,000 |
| Total Liabilities And Equity | $63,080,000 | $67,952,000 | $67,098,000 | $67,984,000 | $67,492,000 |